Virtual Meeting
16:30 – 16:50
Lecture under the auspices of Bristol Myers Squibb:
Current approaches in melanoma in metastatic settings
Hanna Koseła-Paterczyk
20 min
16:50 – 17:05
Cellular therapies, bispecific receptors/antibodies, intratumoral therapies Tomasz Świtaj
15 min
17:05 – 17:25
Uveal melanoma — what we should know in 2026? Paweł Rogala
20 min
17:25 – 17:45
Rare skin tumours Alice Indini
20 min
17:45 – 18:10
Lecture sponsored by Pierre Fabre Médicament:
Personalized therapy for advanced BRAF-positive melanoma — importance of BRAF/MEK inhibitors
Anna M. Czarnecka
25 min
18:10 – 18:25
Lecture sponsored by Medison: When advanced uveal melanoma turns challenging: real‑world oncology practice insights Monika Dudzisz-Śledź
15 min
18:25 – 18:45
How to manage rare toxicities Mario Mandala
20 min
18:45 – 18:55
Lecture sponsored by Pierre Fabre Médicament: Interesting cases Katarzyna Kisielewska
10 min
18:55 – 19:05
Interesting cases Vincas Urbonas
10 min
19:05 – 19:20
Discussion
15 min
Copyrights © 2026 Via Medica